1887

Abstract

In 2006–2007, equine viral arteritis (EVA) was confirmed for the first time in Quarter Horses in multiple states in the USA. The entire genome of an equine arteritis virus (EAV) isolate from the index premises in New Mexico was 12 731 nt in length and possessed a previously unrecorded unique 15 nt insertion in the nsp2-coding region in ORF1a and a 12 nt insertion in ORF3. Sequence analysis of additional isolates made during this disease occurrence revealed that all isolates from New Mexico, Utah, Kansas, Oklahoma and Idaho had 98.6–100.0 % (nsp2) and 97.8–100 % (ORF3) nucleotide identity and contained the unique insertions in nsp2 and ORF3, indicating that the EVA outbreaks in these states probably originated from the same strain of EAV. Sequence and phylogenetic analysis of several EAV isolates made following an EVA outbreak on another Quarter Horse farm in New Mexico in 2005 provided evidence that this outbreak may well have been the source of virus for the 2006–2007 occurrence of the disease. A virus isolate from an aborted fetus in Utah was shown to have a distinct neutralization phenotype compared with other isolates associated with the 2006–2007 EVA occurrence. Full-length genomic sequence analysis of 18 sequential isolates of EAV made from eight carrier stallions established that the virus evolved genetically during persistent infection, and the rate of genetic change varied between individual animals and the period of virus shedding.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/vir.0.019737-0
2010-09-01
2024-03-28
Loading full text...

Full text loading...

/deliver/fulltext/jgv/91/9/2286.html?itemId=/content/journal/jgv/10.1099/vir.0.019737-0&mimeType=html&fmt=ahah

References

  1. Balasuriya, U. B. & MacLachlan, N. J.(2004). The immune response to equine arteritis virus: potential lessons for other arteriviruses. Vet Immunol Immunopathol 102, 107–129.[CrossRef] [Google Scholar]
  2. Balasuriya, U. B., Maclachlan, N. J., De Vries, A. A., Rossitto, P. V. & Rottier, P. J.(1995a). Identification of a neutralization site in the major envelope glycoprotein (GL) of equine arteritis virus. Virology 207, 518–527.[CrossRef] [Google Scholar]
  3. Balasuriya, U. B., Timoney, P. J., McCollum, W. H. & MacLachlan, N. J.(1995b). Phylogenetic analysis of open reading frame 5 of field isolates of equine arteritis virus and identification of conserved and nonconserved regions in the GL envelope glycoprotein. Virology 214, 690–697.[CrossRef] [Google Scholar]
  4. Balasuriya, U. B., Patton, J. F., Rossitto, P. V., Timoney, P. J., McCollum, W. H. & MacLachlan, N. J.(1997). Neutralization determinants of laboratory strains and field isolates of equine arteritis virus: identification of four neutralization sites in the amino-terminal ectodomain of the GL envelope glycoprotein. Virology 232, 114–128.[CrossRef] [Google Scholar]
  5. Balasuriya, U. B., Evermann, J. F., Hedges, J. F., McKeirnan, A. J., Mitten, J. Q., Beyer, J. C., McCollum, W. H., Timoney, P. J. & MacLachlan, N. J.(1998). Serologic and molecular characterization of an abortigenic strain of equine arteritis virus isolated from infective frozen semen and an aborted equine fetus. J Am Vet Med Assoc 213, 1586–1589. [Google Scholar]
  6. Balasuriya, U. B., Hedges, J. F., Nadler, S. A., McCollum, W. H., Timoney, P. J. & MacLachlan, N. J.(1999). Genetic stability of equine arteritis virus during horizontal and vertical transmission in an outbreak of equine viral arteritis. J Gen Virol 80, 1949–1958. [Google Scholar]
  7. Balasuriya, U. B., Dobbe, J. C., Heidner, H. W., Smalley, V. L., Navarrette, A., Snijder, E. J. & MacLachlan, N. J.(2004a). Characterization of the neutralization determinants of equine arteritis virus using recombinant chimeric viruses and site-specific mutagenesis of an infectious cDNA clone. Virology 321, 235–246.[CrossRef] [Google Scholar]
  8. Balasuriya, U. B., Hedges, J. F., Smalley, V. L., Navarrette, A., McCollum, W. H., Timoney, P. J., Snijder, E. J. & MacLachlan, N. J.(2004b). Genetic characterization of equine arteritis virus during persistent infection of stallions. J Gen Virol 85, 379–390.[CrossRef] [Google Scholar]
  9. Balasuriya, U. B., Snijder, E. J., Heidner, H. W., Zhang, J., Zevenhoven-Dobbe, J. C., Boone, J. D., McCollum, W. H., Timoney, P. J. & MacLachlan, N. J.(2007). Development and characterization of an infectious cDNA clone of the virulent Bucyrus strain of equine arteritis virus. J Gen Virol 88, 918–924.[CrossRef] [Google Scholar]
  10. Cavanagh, D.(1997).Nidovirales: a new order comprising Coronaviridae and Arteriviridae. Arch Virol 142, 629–633. [Google Scholar]
  11. Cullinane, A. A.(1993). Equine arteritis virus in an imported stallion. Vet Rec 132, 395 [Google Scholar]
  12. Hamon, M.(2007). L'épidémie normande d'artérite virale de l'été 2007 vue par le praticien. Pratique Vétérinaire Equine 39, 29–34 (in French). [Google Scholar]
  13. Hedges, J. F., Balasuriya, U. B., Timoney, P. J., McCollum, W. H. & MacLachlan, N. J.(1999). Genetic divergence with emergence of novel phenotypic variants of equine arteritis virus during persistent infection of stallions. J Virol 73, 3672–3681. [Google Scholar]
  14. Higgins, A. J.(1993). Equine viral arteritis – a challenge for the British horse industry. Br Vet J 149, 305–306.[CrossRef] [Google Scholar]
  15. Hornyak, A., Bakonyi, T., Tekes, G., Szeredi, L. & Rusvai, M.(2005). A novel subgroup among genotypes of equine arteritis virus: genetic comparison of 40 strains. J Vet Med B Infect Dis Vet Public Health 52, 112–118.[CrossRef] [Google Scholar]
  16. Hullinger, P. J., Gardner, I. A., Hietala, S. K., Ferraro, G. L. & MacLachlan, N. J.(2001). Seroprevalence of antibodies against equine arteritis virus in horses residing in the United States and imported horses. J Am Vet Med Assoc 219, 946–949.[CrossRef] [Google Scholar]
  17. Larsen, L. E., Storgaard, T. & Holm, E.(2001). Phylogenetic characterisation of the GL sequences of equine arteritis virus isolated from semen of asymptomatic stallions and fatal cases of equine viral arteritis in Denmark. Vet Microbiol 80, 339–346.[CrossRef] [Google Scholar]
  18. Li, W. H., Wu, C. I. & Luo, C. C.(1985). A new method for estimating synonymous and nonsynonymous rates of nucleotide substitution considering the relative likelihood of nucleotide and codon changes. Mol Biol Evol 2, 150–174. [Google Scholar]
  19. Lu, Z., Branscum, A. J., Shuck, K. M., Zhang, J., Dubovi, E. J., Timoney, P. J. & Balasuriya, U. B.(2008). Comparison of two real-time reverse transcription polymerase chain reaction assays for the detection of Equine arteritis virus nucleic acid in equine semen and tissue culture fluid. J Vet Diagn Invest 20, 147–155.[CrossRef] [Google Scholar]
  20. McCollum, W. H. & Bryans, J. T.(1973). Serological identification of infection by equine arteritis virus in horses of several countries. In Proceedings of the Third International Conference on Equine Infectious Diseases, Paris, 1972, pp. 256–263. Edited by J. T. Bryans & H. Gerber. Basel, Switzerland: S. Karger.
  21. McCollum, W. H., Timoney, P. J., Lee, J. J. W., Habacker, P. L., Balasuriya, U. B. R. & MacLachlan, N. J.(1999). Features of an outbreak of equine viral arteritis on a breeding farm associated with abortion and fatal interstitial pneumonia in neonatal foals. In Proceedings of the Eighth International Conference on Equine Infectious Diseases, Dubai, United Arab Emirates, 1998, pp. 559–560. Edited by U. Wernery, J. F. Wade, J. A. Mumford & O. R. Kaaden. Newmarket, UK: R & W Publications.
  22. McCue, P. M., Hietala, S. K., Spensley, M. S., Stillian, M., Mihalyi, J. & Hughes, J. P.(1991). Prevalence of equine viral arteritis in California horses. Calif Vet 45, 24–26. [Google Scholar]
  23. Mittelholzer, C., Stadejek, T., Johansson, I., Baule, C., Ciabatti, I., Hannant, D., Paton, D., Autorino, G. L., Nowotny, N. & Belak, S.(2006). Extended phylogeny of equine arteritis virus: division into new subgroups. J Vet Med B Infect Dis Vet Public Health 53, 55–58.[CrossRef] [Google Scholar]
  24. NAHMS(2000). Equine viral arteritis (EVA) and the U.S. horse industry. http://ageconsearch.umn.edu/bitstream/32749/1/eq98eva1.pdf.
  25. OIE(2008). Equine viral arteritis. In OIE Manual of Diagnostic Tests and Vaccines for Terrestrial Animals, 6th edn, pp. 904–918. Paris: World Organisation for Animal Health.
  26. Owens, A.(2005).American Horsepower: the Economic Impact of the Horse Industry on the United States. Washington, DC: American Horse Council Publications.
  27. Pitel, P. H., Legrand, L., Marcillaud-Pitel, C., Miszczak, F., Guix, E., Pronost, S. & Fortier, G.(2007). L'épizootie d'artérite virale equine de 2007: diagnostic et epidemiosurveillance. Pratique Veterinaire Equine 39, 19–27 (in French). [Google Scholar]
  28. Powell, D. G. & Timoney, P. J.(2006). EVA outbreak in New Mexico. Equine Dis Q 15, 2–3. [Google Scholar]
  29. Snijder, E. J. & Meulenberg, J. J.(1998). The molecular biology of arteriviruses. J Gen Virol 79, 961–979. [Google Scholar]
  30. Snijder, E. J. & Spaan, W. J.(2006). Arteriviruses. In Fields Virology, 5th edn, pp. 1337–1355. Edited by D. M. Knipe and P. M. Howley. Philadelphia, PA: Lippincott Williams & Wilkins.
  31. Snijder, E. J., van Tol, H., Pedersen, K. W., Raamsman, M. J. & de Vries, A. A.(1999). Identification of a novel structural protein of arteriviruses. J Virol 73, 6335–6345. [Google Scholar]
  32. Stadejek, T., Bjorklund, H., Bascunana, C. R., Ciabatti, I. M., Scicluna, M. T., Amaddeo, D., McCollum, W. H., Autorino, G. L., Timoney, P. J. & other authors(1999). Genetic diversity of equine arteritis virus. J Gen Virol 80, 691–699. [Google Scholar]
  33. Stadejek, T., Mittelholzer, C., Oleksiewicz, M. B., Paweska, J. & Belak, S.(2006). Highly diverse type of equine arteritis virus (EAV) from the semen of a South African donkey. Acta Vet Hung 54, 263–270.[CrossRef] [Google Scholar]
  34. Tamura, K., Dudley, J., Nei, M. & Kumar, S.(2007). Molecular evolutionary genetics analysis (mega) software version 4.0. Mol Biol Evol 24, 1596–1599.[CrossRef] [Google Scholar]
  35. Thompson, J. D., Gibson, T. J., Plewniak, F., Jeanmougin, F. & Higgins, D. G.(1997). The clustal_x windows interface: flexible strategies for multiple sequence alignment aided by quality analysis tools. Nucleic Acids Res 25, 4876–4882.[CrossRef] [Google Scholar]
  36. Timoney, P. J.(1985). Clinical, virological and epidemiological features of the 1984 outbreak of equine viral arteritis in the thoroughbred population in Kentucky, USA. In Proceedings of the GraysonFoundation International Conference of Thoroughbred Breeders Organizations on Equine Viral Arteritis, Dromoland Castle, Ireland, 1984, pp. 24–33. Lexington, KY: Grayson Found Inc.
  37. Timoney, P. J. & McCollum, W. H.(1988). Equine viral arteritis: epidemiology and control. J Equine Vet Sci 8, 54–59.[CrossRef] [Google Scholar]
  38. Timoney, P. J. & McCollum, W. H.(1993). Equine viral arteritis. Vet Clin North Am Equine Pract 9, 295–309. [Google Scholar]
  39. Timoney, P. J., McCollum, W. H. & Vickers, M. L.(1997). The carrier stallion as a reservoir of equine arteritis virus. Equine Disease Quarterly 6, 2 [Google Scholar]
  40. Timoney, P. J., McCollum, W. H. & Vickers, M. L.(1998). The rationale for greater national control of EVA. Equine Disease Quarterly 7, 2–3. [Google Scholar]
  41. Timoney, P. J., Creekmore, L., Meade, B. J., Fly, D., Rogers, E. & King, B.(2006). Multi-state occurrence of EVA. Report of the Committee on Infectious Diseases of Horses: addressing equine viral arteritis in the United States. In Proceedings of the 110th Annual Meeting of the United States Animal Health Association, pp. 354–362. Minneapolis, MN: Pat Campbell & Associates and Spectrum Press.
  42. van Aken, D., Zevenhoven-Dobbe, J., Gorbalenya, A. E. & Snijder, E. J.(2006). Proteolytic maturation of replicase polyprotein pp1a by the nsp4 main proteinase is essential for equine arteritis virus replication and includes internal cleavage of nsp7. J Gen Virol 87, 3473–3482.[CrossRef] [Google Scholar]
  43. Yamaguchi, S., Kanno, T., Akashi, H. & Kondo, T.(1997). Identification of two neutralisation antigenic sites in GL protein of equine arteritis virus isolates by means of monoclonal antibodies. J Equine Sci 8, 7–11.[CrossRef] [Google Scholar]
  44. Zhang, J., Miszczak, F., Pronost, S., Fortier, C., Balasuriya, U. B., Zientara, S., Fortier, G. & Timoney, P. J.(2007). Genetic variation and phylogenetic analysis of 22 French isolates of equine arteritis virus. Arch Virol 152, 1977–1994.[CrossRef] [Google Scholar]
  45. Zhang, J., Go, Y. Y., Maclachlan, N. J., Meade, B. J., Timoney, P. J. & Balasuriya, U. B.(2008a). Amino acid substitutions in the structural or nonstructural proteins of a vaccine strain of equine arteritis virus are associated with its attenuation. Virology 378, 355–362.[CrossRef] [Google Scholar]
  46. Zhang, J., Timoney, P. J., Maclachlan, N. J. & Balasuriya, U. B.(2008b). Identification of an additional neutralization determinant of equine arteritis virus. Virus Res 138, 150–153.[CrossRef] [Google Scholar]
  47. Zhang, J., Timoney, P. J., MacLachlan, N. J., McCollum, W. H. & Balasuriya, U. B.(2008c). Persistent equine arteritis virus infection in HeLa cells. J Virol 82, 8456–8464.[CrossRef] [Google Scholar]
  48. Ziebuhr, J., Snijder, E. J. & Gorbalenya, A. E.(2000). Virus-encoded proteinases and proteolytic processing in the Nidovirales. J Gen Virol 81, 853–879. [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/vir.0.019737-0
Loading
/content/journal/jgv/10.1099/vir.0.019737-0
Loading

Data & Media loading...

Supplements

vol. , part 9, pp. 2286–2301

Nucleotide and amino acid differences between EAV isolate S3685 and the VB and CW96 strains of EAV.

Genetic evolution of EAV during the 2006–2007 multi-state disease occurrence.

Oligonucleotide primers used for RT-PCR amplification of the full-length genome or partial ORF1a encoding the nsp2 of EAV isolates.

[ Single PDF file] (95 KB)



PDF
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error